» Articles » PMID: 33195153

A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures

Overview
Date 2020 Nov 16
PMID 33195153
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Transmissible spongiform encephalopathies (TSEs) are a group of invariably fatal neurodegenerative disorders. The causal agent is an aberrantly folded isoform (PrP or prion) of the endogenous prion protein (PrP) which is neurotoxic and amyloidogenic and induces misfolding of its physiological counterpart. The intrinsic physical characteristics of these infectious proteinaceous pathogens makes them highly resistant to the vast majority of physicochemical decontamination procedures used typically for standard disinfection. This means prions are highly persistent in contaminated tissues, the environment (surfaces) and, of great concern, on medical and surgical instruments. Traditionally, decontamination procedures for prions are tested on natural isolates coming from the brain of infected individuals with an associated high heterogeneity resulting in highly variable results. Using our novel ability to produce highly infectious recombinant prions we adapted the system to enable recovery of infectious prions from contaminated materials. This method is easy to perform and, importantly, results in highly reproducible propagation . It exploits the adherence of infectious prion protein to beads of different materials allowing accurate and repeatable assessment of the efficacy of disinfectants of differing physicochemical natures to eliminate infectious prions. This method is technically easy, requires only a small shaker and a standard biochemical technique and could be performed in any laboratory.

Citing Articles

Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.

Perez-Castro M, Perez-Castro M, Erana H, Vidal E, Charco J, Lorenzo N PLoS Pathog. 2025; 21(1):e1012890.

PMID: 39841704 PMC: 11774496. DOI: 10.1371/journal.ppat.1012890.


Animal Health Protection - Assessing Antimicrobial Activity of Veterinary Disinfectants and Antiseptics and Their Compliance with European Standards: A Narrative Review.

Tyski S, Bocian E, Laudy A Pol J Microbiol. 2024; 73(4):413-431.

PMID: 39618289 PMC: 11639285. DOI: 10.33073/pjm-2024-043.


Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic.

Heinzer D, Avar M, Pfammatter M, Moos R, Schwarz P, Buhmann M PLoS One. 2024; 19(6):e0304603.

PMID: 38870196 PMC: 11175539. DOI: 10.1371/journal.pone.0304603.


Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation.

Erana H, Diaz-Dominguez C, Charco J, Vidal E, Gonzalez-Miranda E, Perez-Castro M Acta Neuropathol Commun. 2023; 11(1):145.

PMID: 37679832 PMC: 10486007. DOI: 10.1186/s40478-023-01640-8.


Inactivation of Prions by Low-Temperature Sterilization Technology Using Vaporized Gas Derived from a Hydrogen Peroxide-Peracetic Acid Mixture.

Sakudo A, Anraku D, Itarashiki T Pathogens. 2021; 10(1).

PMID: 33396428 PMC: 7824636. DOI: 10.3390/pathogens10010024.

References
1.
Fernandez-Borges N, Erana H, Elezgarai S, Harrathi C, Venegas V, Castilla J . A Quick Method to Evaluate the Effect of the Amino Acid Sequence in the Misfolding Proneness of the Prion Protein. Methods Mol Biol. 2017; 1658:205-216. DOI: 10.1007/978-1-4939-7244-9_15. View

2.
Sehulster L . Prion inactivation and medical instrument reprocessing: challenges facing healthcare facilities. Infect Control Hosp Epidemiol. 2004; 25(4):276-9. DOI: 10.1086/502391. View

3.
Cleaver J, Diener T, Prusiner S . Purified scrapie prions resist inactivation by UV irradiation. J Virol. 1987; 61(1):159-66. PMC: 255227. DOI: 10.1128/JVI.61.1.159-166.1987. View

4.
Simpson D, Masters C, Ohlrich G, Purdie G, Stuart G, Tannenberg A . Iatrogenic Creutzfeldt-Jakob disease and its neurosurgical implications. J Clin Neurosci. 1996; 3(2):118-23. DOI: 10.1016/s0967-5868(96)90003-x. View

5.
Bonda D, Manjila S, Mehndiratta P, Khan F, Miller B, Onwuzulike K . Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus. 2016; 41(1):E10. PMC: 5082740. DOI: 10.3171/2016.5.FOCUS15126. View